The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...